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Preamble 
WHO has developed this rapid advice note to meet the need 
for recommendations on the safe home care for patients with 
suspected novel coronavirus (2019-nCoV) infection 
presenting with mild symptoms and public health measures 
related to management of asymptomatic contacts.  
The document is informed by evidence-based guidelines 
published by WHO, including Infection prevention and 
control of epidemic- and pandemic-prone acute respiratory 
diseases in health care: WHO interim guidance (1), and 
based on the current information available regarding the 
2019-nCoV infection.  
This document is adapted from the original version 
addressing MERS-CoV, which was published in June 2018. 
This rapid advice is intended for public health and infection 
prevention and control (IPC) professionals, health care 
managers, and health care workers. WHO continues to 
monitor the situation closely for any new data that may 
warrant revision of the contents of this rapid advice note.  
Please refer to the following document for 2019-nCoV case 
definition.: https://www.who.int/publications-
detail/surveillance-case-definitions-for-human-infection-
with-novel-coronavirus-(ncov)   
 
Home care for patients with suspected 2019-
nCoV infection presenting with mild symptoms 
In view of the currently limited knowledge of the disease 
caused by 2019-nCoV infection and its transmission 
patterns, WHO recommends that suspected cases of 2019-
nCoV infection be isolated and monitored in a hospital 
setting. This would ensure both safety and quality of health 
care (in case patients’ symptoms worsen) and public health 
security.  
However, for several possible reasons, including situations 
when inpatient care is unavailable or unsafe (i.e. limited 
capacity and resources unable to meet demand for health 
care services), or in a case of informed refusal of 
                                                          
1 These includes home settings.  
2 Low-grade fever, cough, malaise, rhinorrhoea, sore throat without any warning signs, 
such as shortness of breath or difficulty in breathing, increased respiratory (i.e. sputum or 
haemoptysis), gastro-intestinal symptoms such as nausea, vomiting, and/or diarrhoea 
and without changes in mental status (i.e. confusion, lethargy). 
3 A sample checklist is available on page 53 of Infection prevention and control of 
epidemic- and pandemic-prone acute respiratory diseases in health care: (1).  
hospitalization, alternative settings1 for health care provision 
may need to be considered. 
If such a reason exists, patients with mild symptoms2 and 
without underlying chronic conditions such as lung or heart 
disease, renal failure, or immunocompromising conditions 
that place him/her at increased risk of developing 
complications may be cared for in the home environment. 
The same principle of care in the home environment applies 
to symptomatic patients no longer requiring hospitalization. 
This decision requires careful clinical judgment and should 
be informed by assessing the safety of the patient’s home 
environment3. 
A communication link with a health care provider should be 
established for the full duration of the home care period until 
the patient fully recovers. Health care personnel should be 
involved in reviewing the current health status for the 
progression of symptoms3of contacts by phone and, ideally 
and if feasible, by face-to-face visits on a regular (e.g. daily) 
basis, performing specific diagnostic tests as necessary. 
In addition, the patients and the household members should 
be educated on personal hygiene, basic infection prevention 
and control measures, on how to care for the suspected 
infected member of the family as safely as possible, and to 
prevent spread of infection to household contacts.  The 
patient and family should be provided with ongoing support, 
education and monitoring. They should adhere to the 
following recommendations. 
• Place the patient in a well-ventilated single room. 
• Limit the number of caretakers of the patient, ideally 
assign one person who is in a good health without risk 
conditions. No visitors. 
• Household members should stay in a different room or, 
if that is not possible, maintain a distance of at least 1 m 
from the ill person (e.g. sleep in a separate bed)4.  
• Limit the movement of the patient and minimize shared 
space. Ensure that shared spaces (e.g. kitchen, 
bathroom) are well ventilated (e.g. keep windows open). 
• The caregiver should wear a medical mask fitted tightly 
to the face when in the same room with the ill person. 
Masks should not be touched or handled during use. If 
the mask gets wet or dirty with secretions, it must be 
4 An exception may be considered for a breastfeeding mother. Considering the benefits of 
breastfeeding and insignificant role of the breast milk in transmission of other respiratory 
viruses, the mother could continue breastfeeding. The mother should wear a medical 
mask when she is near her baby and perform careful hand hygiene before close contact 
with the baby. She would need also to apply the other hygienic measures described in 
this document.  
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changed immediately. Discard the mask after use and 
perform hand hygiene after removal of the mask. 
• Perform hand hygiene (2) following all contact with ill 
persons or their immediate environment. Hand hygiene 
should also be performed before and after preparing 
food, before eating, after using the toilet, and whenever 
hands look dirty. If hands are not visibly soiled, alcohol-
based hand rub can be used. Perform hand hygiene using 
soap and water when hands are visibly soiled. Address 
safety concerns (e.g. accidental ingestion and fire 
hazards) before recommending alcohol-based hand rubs 
for household use. 
• When using soap and water, disposable paper towels to 
dry hands is desirable.  If not available, use dedicated 
cloth towels and replace them when they become wet. 
• Respiratory hygiene should be practiced by all, 
especially ill persons, at all times. Respiratory hygiene 
refers to covering the mouth and nose during coughing 
or sneezing using medical masks, cloth masks, tissues or 
flexed elbow, followed by hand hygiene. 
• Discard materials used to cover the mouth or nose or 
clean them appropriately after use (e.g. wash 
handkerchiefs using regular soap or detergent and 
water). 
• Avoid direct contact with body fluids, particularly oral 
or respiratory secretions, and stool. Use disposable 
gloves to provide oral or respiratory care and when 
handling stool, urine and waste. Perform hand hygiene 
before and after removing gloves. 
• Gloves, tissues, masks and other waste generated by ill 
persons or in the care of ill persons should be placed in a 
lined container in the ill person’s room before disposal 
with other household waste.4 
• Avoid other types of possible exposure to ill persons or 
contaminated items in their immediate environment (e.g. 
avoid sharing toothbrushes, cigarettes, eating utensils, 
dishes, drinks, towels, washcloths or bed linen). Eating 
utensils and dishes should be cleaned with either soap or 
detergent and water after use and may be re-used instead 
of being discarded. 
• Clean and disinfect frequently touched surfaces such as 
bedside tables, bedframes, and other bedroom furniture 
daily with regular household disinfectant containing a 
diluted bleach5 solution (1-part bleach to 99 parts 
water). 
• Clean and disinfect bathroom and toilet surfaces at least 
once daily with regular household disinfectant 
containing a diluted bleach6 solution (1-part bleach to 99 
parts water). 
• Clean clothes, bedclothes, bath and hand towels, etc. of 
ill persons using regular laundry soap and water or 
machine wash at 60–90 °C with common household 
detergent, and dry thoroughly. Place contaminated linen 
into a laundry bag. Do not shake soiled laundry and 
avoid direct contact of the skin and clothes with the 
contaminated materials. 
• Use disposable gloves and protective clothing (e.g. 
plastic aprons) when cleaning or handling surfaces, 
                                                          
4 Countries may consider measures to ensure that the waste is disposed at a 
sanitary landfill, and not at an unmonitored open dump, wherever possible. 
Additional measures may be needed to prevent unhygienic reuse of gloves, masks, 
clothing or linen soiled with body fluids. Perform hand 
hygiene before and after removing gloves. 
• Persons with symptoms should remain at home until 
their symptoms are resolved based on either clinical 
and/or laboratory findings (two negative RT-PCR tests 
at least 24 hours apart). 
• All household members should be considered contacts 
and their health should be monitored as described 
below. 
• If a household member develops symptoms of acute 
respiratory infection, including fever, cough, sore throat 
and difficult breathing, follow public health 
recommendations below.  
 
Healthcare workers providing home care should do risk 
assessment to select the appropriate PPE.  
 
Management of contacts 
In view of the limited evidence of human-to-human 
transmission of 2019-nCoV, persons (including health care 
workers) who may have been exposed to individuals with 
suspected 2019-nCoV infection should be advised to 
monitor their health for 14 days from the last day of possible 
contact and seek immediate medical attention if they 
develop any symptoms, particularly fever, respiratory 
symptoms such as coughing or shortness of breath, or 
diarrhoea.  
A communication link with a health care provider should be 
established for the duration of the observation period. Health 
care personnel should be involved in reviewing the current 
health status of the contacts by phone and, ideally and if 
feasible, by face-to-face visits on a regular (e.g. daily) basis, 
performing specific diagnostic tests as necessary. 
The healthcare provider should give advance instructions on 
where to seek care when a contact becomes ill, what should 
be the most appropriate mode of transportation, when and 
where to enter the designated health care facility, and what 
infection control precautions should be followed. 
• Notify the receiving medical facility that a symptomatic 
contact will be coming to their facility.  
• While traveling to seek care, the ill person should wear 
a medical mask.  
• Avoid public transportation to the health care facility, if 
possible; call an ambulance or transport the ill person 
with a private vehicle and open the windows of the 
vehicle if possible.  
• The ill contact should be advised to always perform 
respiratory hygiene and hand hygiene; stand or sit as far 
away from others as possible (at least 1 m), when in 
transit and when in the health care facility.  
• Appropriate hand hygiene should be employed by the ill 
contact and caregivers.  
• Any surfaces that become soiled with respiratory 
secretions or body fluids during transport should be 
cleaned and disinfected with regular household 
containing a diluted bleach solution6 (1-part bleach to 99 
parts water). 
syringes and other items, and other hazards occurring from scavenging at waste 
disposal sites. 
5 Most household bleach solutions contain 5% sodium hypochlorite. 




This rapid guidance is based on the MERS-CoV document 
which was developed in consultation with the WHO Global 
Infection Prevention and Control Network and other 
international experts. WHO thanks those who were involved 
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